AXQ Capital’s Erasca ERAS Stock Holding History

AXQ Capital’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,459	Closed	-$76.1K	–	1077
2025 Q4	$76.1K	Buy	+20,459	New	+$57.5K	0.02%	675
2025 Q1	–	Sell	-10,681	Closed	-$26.8K	–	542
2024 Q4	$26.8K	Buy	+10,681	New	+$29.3K	0.01%	409

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

AXQ Capital's ERAS Position: Q1 2026 in Review

AXQ Capital sold out of Erasca (ERAS) in Q1 2026, closing a stake of 20,459 shares — an estimated $76.1K sold.

AXQ Capital first reported a position in ERAS in Q4 2024 and held it in 2 quarters. The position peaked at $76.1K in Q4 2025. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

AXQ Capital reported no remaining Erasca position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 20,459 Erasca shares in Q1 2026, an estimated $76.1K.
AXQ Capital first reported a position in Erasca in Q4 2024 and held it in 2 quarters.
AXQ Capital's Erasca position peaked at $76.1K in Q4 2025.
225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.